Drug-eluting stent implantation could be associated with long-term fscoronary endothelial dysfunction: Comparison between sirolimus-eluting stent and paclitaxel-eluting stent

International Heart Journal

Volumn 48, Issue 5, 2007, Pages 553-567

  Shin, Dong Il ^a   Kim, Pum Joon ^a   Seung, Ki Bae ^a,b   Kim, Dong Bin ^a   Kim, Mi Jeong ^a   Chang, Kiyuk ^a   Lim, Sung Min ^a   Jeon, Doo Soo ^a   Chung, Wung Sung ^a   Baek, Sang Hong ^a   Lee, Man Young ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Acetylcholine; Endothelium; Percutaneous coronary intervention (PCI); Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY STENOSIS; ENDOTHELIUM, VASCULAR; EQUIPMENT DESIGN; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TREATMENT OUTCOME; TUBULIN MODULATORS; VASOCONSTRICTION; VASODILATION;

EID: 36749006562     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.553     Document Type: Article

References (39)

1. Ozcan T, Cin VG, Yurtdas M, et al. Angiographic and clinical outcome following sirolimus-eluting stent (cypher) implantation. Ent Heart J 2007; 48: 11-23.
2. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-elutmg stents inhibit restenosis irrespective of the vessel size. Circulation 2002; 106: 1949-56.
3. Stone GW, Ellis SG; Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent the TAXUS-IV trial. Curulation 2004; 109: 1942-7.
4. Fineschi M, Gori T, Pierli C, et al. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world. Can J Cardiol 2005; 21: 1281-5.
5. Suzuki T, Kopia G; Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-93.
6. Farb A, Heller PF, Shroff S, et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 2001; 104: 473-9.
7. Jeremias A, Sylvia B, Bridges J, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109: 1930-2.
8. Yang J, Wang N, Zhang Y, et al. Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. Int Heart J 2006; 47: 707-13.
9. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-21.
10. Losordo DW, Isner JM, Diaz-Sandoval LJ. Endothelial recovery: the next target in restenosis prevention. Circulation 2003; 107: 2635-7.
11. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasocon-striction. J Am Coll Cardiol 2005; 46: 231-6.
12. Hofma SH, van der Giessen WJ, van Dalen BM, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006; 27: 166-70.
13. Fuke S, Maekawa Y, Kawamoto Y, et al. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007; 71: 220-5.
14. Togni M, Raber L, Cocchia R, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007; 120: 212-20.
15. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990; 81: 1983-91.
16. Takase B, Hamabe A, Satomura K, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J 2006; 70: 49-56.
17. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
18. Asselbergs FW, Monnink SH, Jessurun GA, et al. Assessing the prognostic value of coronary endothelial. Function in patients referred for a first coronary angiogram. Am J Cardiol 2004; 94: 1063-7.
19. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
20. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfimetion. Circulation 2002; 106: 653-8.
21. Sabate M, Kay IP, van Der Giessen WJ, et al. Preserved endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation. Circulation 1999; 100: 1623-9.
22. Hofma SH, van Dalen BK Lemos PA, et al. No change in endothelial-dependent vasomotion late after coronary irradiation. Cardiovasc Radiat Med 2004; 5: 156-61.
23. Vassanelli C, Menegatti G, Zanolla L, Molinari J, Zanotto G, Zardini P. Coronary vasoconstriction in response to acetylcholine after balloon angioplasty: possible role of endothelial dysfunction. Coron Artery Dis 1994; 5: 979-86.
24. Fonseca FA, Izar MC, Fuster V, et al. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis 2001; 154: 61-9.
25. Gomez-Hospital JA, Tenas MS, Cequier Fillat A, et al. Endothelial function in coronary segments previously treated with balloon angioplasty. Rev Esp Cardiol 2000; 53: 1467-73.
26. Caramori PR, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG. Long-term endothelial dyslunction after coronary artery stenting. J Am Coll Cardiol 1999; 34: 1675-9.
27. Shimokawa H, Flavahan NA, Shepherd JT, Vanhoutte PM. Endothielium-dependent inhibition of ergonovine-induced contraction is impaired in porcine coronary arteries with regenerated endothelium. Circulation 1989; 80: 643-50.
28. van Beusekom HM, Whelan DM, Hofma SH, et al. Loog-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998; 32: 1109-17.
29. Weidinger FF, McLenachan JM, Cybulsky MI, et al. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 1990; 81: 1667-79.
30. Blinn A, Schneider DJ, Sobel BE, Dauerman HL. Endothelial dysfunction and inflammation after percutaneous coronary intervention. Am J Cardiol 2004; 94: 1420-3.
31. van Beusekom HM, Whelan DM, Hofma SH, et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine-coronary arteries. J Am Coll Cardiol 1998; 32: 1109-17.
32. Shirakabe A, Takano H, Nakamura S, et al. Coronary perforation during percutaneous coronary intervention. Int Heart J 2007; 48: 1-9.
33. Mohacsi PJ, Tuller D, Hulliger B, Wijngaard PL. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell gmwth factor. J Heart Lung Transplant 1997; 16: 484-92.
34. Fukuda D, Sata M, Tanaka K, Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 2005; 111: 926-31.
35. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
36. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 2004; 109: 701-5.
37. Sousa JE, Costa MA, Farb A, et al. Images in cardiovascular medicine. Vasculur healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation 2004; 110: e5-6.
38. Inuoe T, Sata M, Hikichi Y, et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007; 115: 553-61.
39. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.